Qi Biodesign
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A synthetic biology firm engineering microbes to produce high-value chemicals and therapeutic compounds through metabolic pathway design.
Metabolic DisordersInfectious DiseaseOncology
Technology Platform
A proprietary synthetic biology platform that uses computational design and automated strain engineering to construct novel metabolic pathways in microbes.
Opportunities
Strong government support for bio-manufacturing in China and growing demand for sustainable production methods across industries.
Risk Factors
High technical and scaling risks, with long development timelines and significant capital requirements for fermentation infrastructure.
Competitive Landscape
Competes with global synthetic biology leaders like Ginkgo Bioworks and Zymergen, as well as domestic Chinese academies and startups.